News & Perspective

Dec 22, 2008

Dec 22, 2008

FDA approves shortened anthrax-vaccine course

(CIDRAP News) – The US Food and Drug Administration (FDA) recently approved a new version of BioThrax—the nation's only licensed anthrax vaccine—that requires fewer doses and changes the injection route.

Dec 22, 2008

Dec 22, 2008

EU panel supports innovative pandemic, seasonal flu vaccines

(CIDRAP News) – An H5N1 influenza vaccine made by Baxter International could become the first cell culture–based H5N1 influenza vaccine to be approved for marketing, following its endorsement by a committee of the European Medicines Agency (EMEA) last week.

Recommendations of the Committee for Medicinal Products for Human Use (CHMP) are usually followed by the EMEA within a few months.

Dec 16, 2008

Dec 16, 2008

Treatment comes first in HHS antiviral guidance

Editor's note: This story was revised Dec 17 to include an item that was mistakenly left out of the list of five main recommendations on antiviral use in a pandemic.

Dec 03, 2008

Dec 03, 2008

USDA drafts avian flu risk assessment for poultry and egg products

(CIDRAP News) – The US Department of Agriculture (USDA) yesterday released a draft of its risk assessment for contracting highly pathogenic avian influenza from eating poultry products, shell eggs, and egg products, a tool that could be used to reduce human illness from the virus and help target messages to consumers.

Dec 02, 2008

Dec 02, 2008

FDA details year's progress on food protection plan

(CIDRAP News) – The US Food and Drug Administration (FDA) released a report yesterday detailing the first year of accomplishments in implementing its Food Protection Plan, a road map the agency presented in November 2007 in response to a spate of contamination incidents involving domestic and imported food.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»